Credit Suisse analyst, Martin Auster, reiterated his Underperform rating on shares of United Therapeutics Corp. (NASDAQ: UTHR) but raised his ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE